• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Elara Caring Secures New Strategic Investment from Ares and DaVita

    2/2/26 3:00:00 PM ET
    $ARES
    $DVA
    Investment Managers
    Finance
    Misc Health and Biotechnology Services
    Health Care
    Get the next $ARES alert in real time by email

    Partnership will accelerate Elara's growth and evolution as home health care leader; expand access to high-acuity care for complex diseases through new offerings

    Elara Caring (Elara), a leading national provider of skilled home health, hospice, behavioral health, and personal care services, today announced that it has entered into an agreement for a strategic investment from Ares' Private Equity Group (Ares) and DaVita. The investment is intended to expand access to personalized, clinically advanced care at home for patients with complex and acute needs. Elara will continue to operate as a wholly independent company led by CEO Ananth Mohan and the current management team. Following the closing, the parties will collaborate to help Elara expand access to care through new care models and clinical programs.

    The investment from Ares and DaVita will support Elara's next phase of growth by helping to expand its capacity to deliver specialized, in-home care and launch innovative care models. With Ares' experience growing high-performing healthcare businesses and DaVita's clinical and operational expertise in value-based care, Elara is well positioned to scale programs designed to improve outcomes and address gaps in post-acute care—bringing more consistent support to patients at home.

    "Too often, home-based care is introduced late in the care journey, significantly impacting outcomes and quality of life, especially with our vulnerable populations," said Ananth Mohan, Elara Caring CEO. "This collaboration reflects a shared belief that care should be timelier, more personalized, and meet patients where they are most comfortable—at home. Together with Ares and DaVita, we have an extraordinary opportunity to improve the management of chronic conditions and deliver better results for patients and their loved ones as well as our healthcare system overall. We are thrilled to welcome them as partners."

    "Elara Caring is a leading home care platform defined by a commitment to quality and a patient-first culture," said Kevin Cox, Partner in Ares' Private Equity Group. "We're excited to partner with the Elara team and support their next phase of growth and innovation—expanding access, improving outcomes, and delivering an outstanding experience for patients and team members."

    As a key focus of the investment, DaVita and Elara intend to co‑develop a kidney‑specific home‑based care model. This new model will build upon Elara's existing clinical capabilities and apply DaVita's advanced clinical insights to meet the unique needs of patients with kidney disease, seeking to reduce preventable hospitalizations, and helping to lower the total cost of care. The program will seek to offer patients a new pathway to receive high‑quality, tailored support in the comfort of their own homes, and empower providers with a vital resource to ensure high-touch, continuity of care.

    "Through our integrated care programs, we saw meaningful differences in patient outcomes that were closely tied to the quality of home‑based support they received," said Steve Phillips, Chief Strategy Officer of DaVita. "Strengthening access to Elara Caring's exceptional services will help more patients maintain stability at home, avoid unnecessary hospitalizations, and ultimately experience a better quality of life."

    The closing of the transaction is subject to customary closing conditions, including receipt of regulatory approvals, and is expected to occur later in 2026. The terms of the transaction were not disclosed.

    Harris Williams and Evercore are serving as financial advisors, Skadden, Arps, Slate, Meagher & Flom LLP is serving as legal counsel and Debevoise & Plimpton LLP is serving as financing counsel for Elara Caring. Guggenheim Securities, LLC is serving as financial advisor and Ropes & Gray LLP and McDermott Will & Schulte are serving as legal advisors to Ares and DaVita.

    About Elara Caring

    Elara Caring is among the nation's leading providers of high-quality, value-based home care, offering Skilled Home Health, Hospice, Personal Care Services, Behavioral Health, and Palliative Care. With a footprint in 18 states, it serves more than 60,000 patients and clients daily across 200 locations. At Elara, care is delivered by skilled, compassionate professionals dedicated to supporting patients with expertise and empathy. Through care innovation and a commitment to excellence, Elara ensures patients receive the right care when and where they need it most.

    About Ares Management

    Ares Management Corporation (NYSE:ARES) is a leading global alternative investment manager offering clients complementary primary and secondary investment solutions across the credit, real estate, private equity and infrastructure asset classes. We seek to advance our stakeholders' long-term goals by providing flexible capital that supports businesses and creates value for our investors and within our communities. By collaborating across our investment groups, we aim to generate consistent and attractive investment returns throughout market cycles. As of September 30, 2025, Ares Management Corporation's global platform had over $595 billion of assets under management, with operations across North America, South America, Europe, Asia Pacific and the Middle East. For more information, please visit www.aresmgmt.com.

    About DaVita Inc.

    DaVita (NYSE:DVA) is a health care provider focused on transforming care delivery to improve quality of life for patients globally. As a comprehensive kidney care provider, DaVita has been a leader in clinical quality and innovation for 25 years. DaVita cares for patients at every stage and setting along their kidney health journey—from slowing the progression of kidney disease to helping to support transplantation, from acute hospital care to dialysis at home. As of September 30, 2025, DaVita served approximately 293,200 patients at 3,247 outpatient dialysis centers, of which 2,662 centers were located in the United States and 585 centers were located in 14 other countries worldwide. DaVita has reduced hospitalizations, improved mortality, helped improve health access and worked collaboratively to propel the kidney care community to adopt a higher quality standard of care for all patients, everywhere. To learn more, visit DaVita.com/About.

    View source version on businesswire.com: https://www.businesswire.com/news/home/20260202982929/en/

    Elara Caring Media Contact:

    Sharon Horowitz

    [email protected]

    631-807-8149



    Ares Management Contact:

    [email protected]



    DaVita Media Contact:

    [email protected]

    Get the next $ARES alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ARES
    $DVA

    CompanyDatePrice TargetRatingAnalyst
    Ares Management Corporation
    $ARES
    12/11/2025$201.00Neutral
    UBS
    Ares Management Corporation
    $ARES
    10/14/2025$180.00Perform → Outperform
    Oppenheimer
    Ares Management Corporation
    $ARES
    10/3/2025$156.00Market Perform
    BMO Capital Markets
    Ares Management Corporation
    $ARES
    7/28/2025Mkt Perform
    Raymond James
    Ares Management Corporation
    $ARES
    5/15/2025Outperform → Perform
    Oppenheimer
    Ares Management Corporation
    $ARES
    4/16/2025$159.00Perform → Outperform
    Oppenheimer
    Ares Management Corporation
    $ARES
    4/8/2025$165.00Mkt Perform → Mkt Outperform
    Citizens JMP
    Ares Management Corporation
    $ARES
    1/27/2025$224.00Overweight
    Barclays
    More analyst ratings

    $ARES
    $DVA
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    UBS resumed coverage on Ares Management with a new price target

    UBS resumed coverage of Ares Management with a rating of Neutral and set a new price target of $201.00

    12/11/25 9:03:09 AM ET
    $ARES
    Investment Managers
    Finance

    Ares Management upgraded by Oppenheimer with a new price target

    Oppenheimer upgraded Ares Management from Perform to Outperform and set a new price target of $180.00

    10/14/25 8:34:20 AM ET
    $ARES
    Investment Managers
    Finance

    BMO Capital Markets initiated coverage on Ares Management with a new price target

    BMO Capital Markets initiated coverage of Ares Management with a rating of Market Perform and set a new price target of $156.00

    10/3/25 8:36:59 AM ET
    $ARES
    Investment Managers
    Finance

    $ARES
    $DVA
    Leadership Updates

    Live Leadership Updates

    View All

    Ares Management Set to Join S&P 500; Sezzle and Vital Farms to Join S&P SmallCap 600

    NEW YORK, Dec. 8, 2025 /PRNewswire/ -- S&P Dow Jones Indices will make the following changes to the S&P 500 and S&P SmallCap 600:  Ares Management (NYSE:ARES) will replace Kellanova (NYSE:K) in the S&P 500 effective prior to the open of trading on Thursday, December 11. Mars Inc. is acquiring Kellanova in a deal expected to close soon, pending final closing conditions.Vital Farms Inc. (NASD: VITL) will replace Heidrick & Struggles Intl Inc. (NASD: HSII) in the S&P SmallCap 600 effective prior to the opening of trading on Thursday, December 11. Advent International and Corvex Private Equity are acquiring Heidrick & Struggles Intl in a deal expected to be completed soon, pending final closing

    12/8/25 5:57:00 PM ET
    $ARES
    $CRGY
    $HSII
    Investment Managers
    Finance
    Oil & Gas Production
    Energy

    Aspida Holdings Ltd. Appoints Suzanne Sadlier As Head of Regulatory Affairs

    Durham, NC, Nov. 20, 2025 (GLOBE NEWSWIRE) -- Aspida Holdings Ltd. ("Aspida"), a life insurance and annuity company, announced today the appointment of Suzanne Sadlier as Head of Regulatory Affairs. In this role, Ms. Sadlier will oversee regulatory engagement across Aspida's U.S., Bermuda, and Cayman platforms. Ms. Sadlier brings more than two decades of leadership in international insurance, captive management, and regulatory oversight. She previously served as Executive Vice President of Captive Management at Artex Risk Solutions, overseeing strategic operations across multiple regions with 80+ indirect reports and P&L responsibility for six business strategies including P&C reinsuran

    11/20/25 8:00:00 AM ET
    $ARES
    Investment Managers
    Finance

    Ares Management Appoints Bill Benjamin to Vice Chairman Role

    Julie Solomon to Continue Leading Growth of Real Estate Business Ares Management Corporation (NYSE:ARES) ("Ares"), a leading global alternative investment manager, announced today that it has appointed Bill Benjamin, current Co-Head of Ares Real Estate, to the newly created position of Vice Chairman of Ares, effective January 1, 2026. The Ares Real Estate team will continue to be led by Julie Solomon as the global Head of Real Estate. In his role as Vice Chairman, Mr. Benjamin will report to Kipp deVeer and Blair Jacobson, Co-Presidents of Ares, and will remain based in London. He will continue to focus on partnering with Real Estate leadership on strategic initiatives and relationships

    10/20/25 6:30:00 AM ET
    $ARES
    Investment Managers
    Finance

    $ARES
    $DVA
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    DaVita Inc. 4th Quarter 2025 Results

    DENVER, Feb. 2, 2026 /PRNewswire/ -- DaVita Inc. (NYSE:DVA) announced financial and operating results for the quarter and year ended December 31, 2025. "Our strong platform delivered once again in 2025, providing high quality, innovative care to our patients and achieving the financial targets we set out at the beginning of the year despite a challenging environment," said Javier Rodriguez, CEO of DaVita. "Given our ongoing investments and process improvements, we are confident in our ability to continue to deliver both clinically and financially in 2026 and beyond." Financial and operating highlights for the quarter and year ended December 31, 2025: Consolidated revenues were $3.620 billion

    2/2/26 4:05:00 PM ET
    $DVA
    Misc Health and Biotechnology Services
    Health Care

    Elara Caring Secures New Strategic Investment from Ares and DaVita

    Partnership will accelerate Elara's growth and evolution as home health care leader; expand access to high-acuity care for complex diseases through new offerings Elara Caring (Elara), a leading national provider of skilled home health, hospice, behavioral health, and personal care services, today announced that it has entered into an agreement for a strategic investment from Ares' Private Equity Group (Ares) and DaVita. The investment is intended to expand access to personalized, clinically advanced care at home for patients with complex and acute needs. Elara will continue to operate as a wholly independent company led by CEO Ananth Mohan and the current management team. Following the cl

    2/2/26 3:00:00 PM ET
    $ARES
    $DVA
    Investment Managers
    Finance
    Misc Health and Biotechnology Services
    Health Care

    Ares Capital Corporation Announces Tax Reporting Information for Calendar Year 2025

    Ares Capital Corporation ("Ares Capital" or the "Company") (NASDAQ:ARCC) announced today the tax treatment of the Company's 2025 common stock distributions (CUSIP #: 04010L103).       Ordinary Income Per Share     Record Date Payable Date Total Paid Per Share Ordinary Rate 20% Rate (1) Long Term Capital Gains per Share (2) Interest - Related Dividends (3) 3/14/2025 3/31/2025 $ 0.4800 $ 0.339128 $ 0.140872 $ 0.0000 84.7500% 6/13/2025 6/30/2025 $ 0.4800 $ 0.339128 $ 0.140872 $ 0.0000 84.7500% 9/15/2

    1/30/26 4:00:00 PM ET
    $ARCC
    $ARES
    Finance: Consumer Services
    Finance
    Investment Managers

    $ARES
    $DVA
    SEC Filings

    View All

    DaVita Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

    8-K - DAVITA INC. (0000927066) (Filer)

    2/2/26 4:07:00 PM ET
    $DVA
    Misc Health and Biotechnology Services
    Health Care

    Amendment: SEC Form SCHEDULE 13G/A filed by Ares Management Corporation

    SCHEDULE 13G/A - Ares Management Corp (0001176948) (Subject)

    1/30/26 1:26:40 PM ET
    $ARES
    Investment Managers
    Finance

    Amendment: SEC Form SCHEDULE 13G/A filed by Ares Management Corporation

    SCHEDULE 13G/A - Ares Management Corp (0001176948) (Subject)

    1/21/26 12:30:29 PM ET
    $ARES
    Investment Managers
    Finance

    $ARES
    $DVA
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    General Counsel Sagati Aghili Naseem sold $299,239 worth of shares (1,849 units at $161.84), decreasing direct ownership by 0.72% to 254,671 units (SEC Form 4)

    4 - Ares Management Corp (0001176948) (Issuer)

    1/26/26 6:22:20 PM ET
    $ARES
    Investment Managers
    Finance

    Co-President Jacobson Blair covered exercise/tax liability with 2,093 shares, decreasing direct ownership by 0.24% to 858,221 units (SEC Form 4)

    4 - Ares Management Corp (0001176948) (Issuer)

    1/22/26 5:21:14 PM ET
    $ARES
    Investment Managers
    Finance

    Chief Financial Officer Phillips Jarrod was granted 2,712 shares and covered exercise/tax liability with 1,683 shares, increasing direct ownership by 0.42% to 243,377 units (SEC Form 4)

    4 - Ares Management Corp (0001176948) (Issuer)

    1/22/26 5:20:30 PM ET
    $ARES
    Investment Managers
    Finance

    $ARES
    $DVA
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Bhutani Ashish bought $1,413,300 worth of shares (10,000 units at $141.33), increasing direct ownership by 77% to 22,905 units (SEC Form 4)

    4 - Ares Management Corp (0001176948) (Issuer)

    3/13/25 8:14:14 PM ET
    $ARES
    Investment Managers
    Finance

    Ares Management Llc bought $2,838,930 worth of shares (150,000 units at $18.93) (SEC Form 4)

    4 - Ares Management Corp (0001176948) (Reporting)

    10/20/23 6:27:39 PM ET
    $ARES
    Investment Managers
    Finance

    Ares Management Llc bought $2,219,490 worth of shares (150,000 units at $14.80) (SEC Form 4)

    4 - Ares Management Corp (0001176948) (Reporting)

    10/4/23 4:28:51 PM ET
    $ARES
    Investment Managers
    Finance

    $ARES
    $DVA
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Ares Management Corporation

    SC 13G/A - Ares Management Corp (0001176948) (Subject)

    11/14/24 4:06:22 PM ET
    $ARES
    Investment Managers
    Finance

    Amendment: SEC Form SC 13G/A filed by Ares Management Corporation

    SC 13G/A - Ares Management Corp (0001176948) (Subject)

    11/14/24 4:05:07 PM ET
    $ARES
    Investment Managers
    Finance

    SEC Form SC 13G/A filed by DaVita Inc. (Amendment)

    SC 13G/A - DAVITA INC. (0000927066) (Subject)

    2/13/24 5:02:42 PM ET
    $DVA
    Misc Health and Biotechnology Services
    Health Care

    $ARES
    $DVA
    Financials

    Live finance-specific insights

    View All

    DaVita Inc. 4th Quarter 2025 Results

    DENVER, Feb. 2, 2026 /PRNewswire/ -- DaVita Inc. (NYSE:DVA) announced financial and operating results for the quarter and year ended December 31, 2025. "Our strong platform delivered once again in 2025, providing high quality, innovative care to our patients and achieving the financial targets we set out at the beginning of the year despite a challenging environment," said Javier Rodriguez, CEO of DaVita. "Given our ongoing investments and process improvements, we are confident in our ability to continue to deliver both clinically and financially in 2026 and beyond." Financial and operating highlights for the quarter and year ended December 31, 2025: Consolidated revenues were $3.620 billion

    2/2/26 4:05:00 PM ET
    $DVA
    Misc Health and Biotechnology Services
    Health Care

    Ares Capital Corporation Announces Tax Reporting Information for Calendar Year 2025

    Ares Capital Corporation ("Ares Capital" or the "Company") (NASDAQ:ARCC) announced today the tax treatment of the Company's 2025 common stock distributions (CUSIP #: 04010L103).       Ordinary Income Per Share     Record Date Payable Date Total Paid Per Share Ordinary Rate 20% Rate (1) Long Term Capital Gains per Share (2) Interest - Related Dividends (3) 3/14/2025 3/31/2025 $ 0.4800 $ 0.339128 $ 0.140872 $ 0.0000 84.7500% 6/13/2025 6/30/2025 $ 0.4800 $ 0.339128 $ 0.140872 $ 0.0000 84.7500% 9/15/2

    1/30/26 4:00:00 PM ET
    $ARCC
    $ARES
    Finance: Consumer Services
    Finance
    Investment Managers

    DaVita Inc. Schedules 4th Quarter 2025 Investor Conference Call

    DENVER, Jan. 21, 2026 /PRNewswire/ -- DaVita Inc. (NYSE:DVA), announced today that it will hold its quarterly conference call to discuss fourth quarter results on Monday, February 2, 2026 at 5:00 p.m. Eastern Time. The company plans to release its results after market close the same day. This call is also being webcast and can be accessed at the DaVita IR web page. You can join this call as follows:  Monday, February 2, 2026Starting at 5:00 p.m. ESTWebcast can be accessed using this link Dial in number: 877-918-6630International dial in: 517-308-9042 When calling in, please provide the operator the password "Earnings" and provide your name and company affiliation. Investors unable to listen

    1/21/26 10:00:00 AM ET
    $DVA
    Misc Health and Biotechnology Services
    Health Care